CPRX - Catalyst Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 8 2023 | Benzinga
CORAL GABLES, Fla., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ:CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that it will release its third-quarter 2023 financial results after market close on Wednesday, November 8, 2023.
Catalyst's management team will host a conference call and webcast the following morning, Thursday, November 9, 2023, at 8:30 AM ET, to discuss the Company's financial results and provide a corporate update.
Conference Call & Webcast Details
| Date/Time: |
| November 9, 2023, at 8:30 AM ET |
| US/Canada Dial-in Number: |
| (877) 407-8912 |
| International Dial-in Number: |
| (201) ... |